Biomarkers: an important tool in the characterization of dementia

Ian McKeith

Ian McKeith, FMedSci, MD, FRSB, FRCPsych from Newcastle University, Newcastle, UK talks to us the importance of biomarkers in the characterization of patients suffering from dementia, and discusses a common misunderstanding about their use for this purpose. This interview was recorded at the 2017 Alzheimer’s Association International Conference (AAIC) held in London, UK.

Share this video  
Similar topics
Related videos
0:57
Microglial proteins in the brain: the good, the bad and the ugly
Delphine Boche
2:29
Late and early-onset AD: understanding the differences
Liana Apostolova
0:33
The lack of new data for Alzheimer's disease research: what can be done?
Pieter Jelle Visser
1:02
Clearing up: approaches to treat Parkinson's disease
Jeffrey Kordower
2:31
Tau fragments as novel disease biomarkers: a pilot study for a plasma protein signature for AD
Nigel Hooper
Alzheimer’s Disease, Dementia, Dementia with Lewy Bodies
AAIC 2017
Interview
More from Ian McKeith
Making HEADWAY into research for DLB
Guidelines for the diagnosis of DLB
The content of VJDementia is intended for healthcare professionals